UROTHELIAL CANCER
Clinical trials for UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study compares immunotherapy options for advanced bladder cancer patients
Disease control CompletedThis observational study followed 35 adults with advanced urothelial (bladder) cancer that did not worsen after initial chemotherapy. Participants received either avelumab as first-line maintenance therapy or pembrolizumab as second-line therapy. Researchers tracked how long the …
Matched conditions: UROTHELIAL CANCER
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New clip may make cancer surgery safer
Disease control CompletedThis study tested a new surgical clip called VasoClip in 40 people having robotic surgery for prostate, kidney, or bladder cancer. The clip is designed to grip better and prevent slipping during surgery. Researchers compared it to a standard clip to see if it works just as well o…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: Incheon St.Mary's Hospital • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
Immunotherapy combo shows promise in slowing advanced bladder cancer
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help delay cancer growth in people with advanced urothelial cancer that did not worsen after initial chemotherapy. The trial enrolled 25 adults whose cancer was not removable by surg…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Bladder cancer drug avelumab shows promise as Long-Term maintenance therapy
Disease control CompletedThis study looked at how well the drug avelumab works as a maintenance treatment for people with advanced bladder cancer that hasn't gotten worse after initial chemotherapy. The study included 106 adults and followed them for about 4 years to track safety and how long they lived.…
Matched conditions: UROTHELIAL CANCER
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New drug outperforms chemo in advanced bladder cancer trial
Disease control CompletedThis study tested a new drug called enfortumab vedotin against standard chemotherapy in 608 adults with advanced bladder or urinary tract cancer that had worsened after prior treatment. The goal was to see if the new drug helped people live longer and slowed cancer growth. Result…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 06, 2026 16:01 UTC